According to a new study by UCLA (University of California, Los Angeles), the popular sports supplement creatine can enhance the immune system’s fight against tumors. The findings, published in the journal iScience<\/i>, demonstrate that creatine boosts the activity of dendritic cells, which recognize tumors and activate killer T-cells.<\/p>\n
Currently, existing cancer immunotherapy is effective in only 20% to 40% of patients. Researchers state that improving the function of dendritic cells\u2014which coordinate the action of killer T-cells\u2014could make the treatment successful for a larger number of people. Creatine acts as a sort of “rechargeable battery” for cells, helping them sustain energy within the tumor environment.<\/p>\n
Experiments conducted on mice and human cells showed that daily injections of creatine significantly slowed tumor growth in melanoma models. Furthermore, the supplement proved effective in laboratory settings for improving the quality of dendritic cell-based anti-cancer vaccines.<\/p>\n
The scientists emphasize that the research is in its early stages and has not yet been tested on cancer patients. Consequently, the results should not be interpreted as proof that creatine supplements improve cancer treatment in humans. The researchers urge patients to consult their treating physicians before taking any supplements, until formal clinical trials begin.<\/p>\n